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ABSTRACT
Objective: This study aimed to prepare and characterize anti-acne ethosomes using the cold- and thin-layer hydration methods.
Methods: A sonication step was included during ethosome preparation to improve the quality of the cold method. Azelaic acid, Phospholipon 90G, 
ethanol, propylene glycol, and phosphate buffer (pH 7.4) were used in the procedures. Prepared ethosomal suspensions were characterized using 
transmission electron microscopy, particle-size analysis, and spectrophotometry.
Results: Ethosomes prepared using the thin-layer hydration method (F1) had small unilamellar vesicles, while those prepared using the cold method 
with 15-min sonication (F4) showed spherical, elliptical, unilamellar, and multilamellar vesicles. F1 ethosomes had a Dmean volume of 648.57±231.26, 
whereas those prepared using the cold method with 5- (F2), 10- (F3), and 15-min (F4) sonication had Dmean volumes of 2734.04±231.49 nm, 
948.90±394.52 nm, and 931.69±471.84 nm, respectively. Polydispersity indices of F2, F3, and F4 ethosomes were 0.74±0.21, 0.86±0.05, and 0.91±0.03, 
respectively, with a poor particle-size distribution, compared to that of F1 (0.39±0.01). Zeta potentials of F1–F4 ethosomes were −38.27±1.72 mV, 
−23.53±1.04 mV, −31.4±1.04 mV, and −34.3±1.61 mV, respectively. Entrapment efficiencies of F1–F4 ethosomes were 90.71±0.11%, 53.84±3.16%, 
72.56±0.28%, and 75.11±1.42%, respectively.
Conclusion: Anti-acne ethosomes produced using the thin-layer hydration method had superior properties than those produced using the cold 
method with 15-min sonication.
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INTRODUCTION
Azelaic acid is a compound effective in treating mild-to-moderate acne 
when formulated in 20% w/w cream and applied topically. Azelaic 
acid works by preventing the growth of skin bacteria causing acne, 
Propionibacterium acnes and Staphylococcus epidermis, due to its 
bactericidal properties. In addition, it has bacteriostatic properties 
against some aerobic microorganisms [1]. Azelaic acid is soluble in 
ethanol and slightly soluble in water [2] and, therefore, is compatible 
with ethosome formulations. Ethosomes are lipid vesicles with a high 
ethanol concentration. They consist of a phospholipid bilayer with 
hydrophilic heads and hydrophobic tails enabling entrapment of 
lipophilic or hydrophilic drugs.
Ethosomes are special type of ultra deformable vesicles. Consisting 
essentially of phospholipids, water, and a high quantity of ethanol [3]. They 
are smaller, softer, and more flexible than liposomes. These properties 
result in higher drug penetration and transdermal absorption [4]. 
Soya or egg phospholipids are usually used for ethosome preparation 
(i.e., phosphatidylcholine and phosphatidylinositol) at concentrations of 
0.5–10% w/v. Ethanol is usually used at 20–45% v/v concentrations as a 
penetration enhancer [3].
There are several methods of preparing ethosomes, including hot, 
cold, and thin-layer hydration methods. In the thin-layer hydration 
method, phospholipids are dissolved in an organic solvent, and a thin-
layer lipid film is formed using a rotary vacuum evaporator. Organic 
solvents and rotary vacuum evaporation are not needed in the cold 
method, making it more practical, time-saving, and economical than 
thin-layer hydration. Moreover, thermodynamically unstable active 
compounds cannot be formulated using thin-layer hydration because 
the process requires higher temperatures (below lipid transition 
temperatures) to evaporate the organic solvents. However, if the 
drug is thermostable and its solubility increases with temperature, 
thin-layer hydration should be used because it can increase drug 
entrapment efficiency. Mistry and Ravikumar reported that the cold 
method produces azelaic ethosomes with an entrapment efficiency 
of 35–43% which was lower than that resulting from the thin-layer 
hydration method (55–88%) [5]. Mbah et al. prepared metronidazole 
ethosomes using the thin-layer hydration method with an entrapment 
efficiency of 50.31±3.38%, average particle size of 179.9 nm, and 
a polydispersity index (PDI) of 0.338 [6]. Linoleic acid ethosomes 
prepared using the cold method had an entrapment efficiency of 
64.37±5.91%, average particle size of 343.10±32.49 nm, and a PDI of 
0.105±0.012 [7]. Ethosome formulations and the preparation methods 
affect the quality of ethosomes produced.
The size and lamellarity of ethosomes are very crucial in topical and 
transdermal drug delivery. The vesicle size should be <200 or 300 nm. In 
both the cold and thin-layer hydration methods, ethosomal suspensions 
are extruded or sonicated to obtain the required size and lamellarity. 
The extrusion process is performed by extruding the suspension under 
low pressure for certain cycles through polycarbonate membranes 
(50–300 nm). Sonication can be performed using either a probe 
sonicator or an ultrasonic bath. Sonication and extrusion will produce 
small unilamellar vesicle (SUVs). Maestrelli et al. showed that the vesicle 
size produced through sonication (189.3±13.7 nm) was smaller than that 
via extrusion (295.8±33.2 nm) [8]. Chen et al. reported that entrapment 
efficiency of triptolide ethosomes increased with increase in sonication 
time until a specific limit; however, the entrapment efficiency of extrusion 
was higher than that of sonication [9]. In addition to formulations and 
preparation methods, size reduction processes also affect ethosome 
properties significantly. Therefore, further studies are needed to observe 
how such processes can improve the quality of ethosomes.
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In the present study, preparations of anti-acne ethosomes containing 
azelaic acid were done using two different methods, the cold- and thin-
layer hydration methods. The inclusion of a sonication step in the cold 
method was done to increase the quality of the ethosomes produced. 
Then, the particle-size analysis, transmission electron microscopy 
(TEM), and ultraviolet and visible (UV-Vis) spectrophotometry were 
used to characterize the suspensions.
MATERIALS AND METHODS
Materials
Azelaic acid (Sigma-Aldrich, Jerman), ethanol (Brataco, Indonesia), 
Phospholipon 90G (Lipoid GmbH, Jerman), dichloromethane 
(Brataco, Indonesia), methanol (Brataco, Indonesia), propylene 
glycol (Brataco, Indonesia), demineralized water (Brataco, 
Indonesia), sodium hydroxide (Brataco, Indonesia), and sodium 
dihydrogen phosphate monobasic (Brataco, Indonesia) were of high-
performance liquid chromatography grade. All the other materials 
were of analytical grade.
Thermal analysis
Thermal analysis was performed using differential scanning calorimetry 
(DSC) to observe the transition temperature of Phospholipon 90G with 
STA 6000 (Perkin Elmer, USA). 35.528 mg Phospholipon 90G was 
placed in a closed plate and heated from 30.00°C to 1000.00°C at a rate 
of 10.00°C/min and constant nitrogen flow (20 mL/min).
Preparation of anti-acne ethosomes
Thin-layer hydration method
Table 1 shows the formulations of the cold- and thin-layer hydration 
methods. The procedure followed a method developed by Wirarti [10] 
with slight modifications. For 25 mL of ethosomal suspension, 500 mg 
Phospholipon 90G was dissolved in 5 mL dichloromethane and added 
into a clean and dry round bottom flask. The organic solvent was removed 
using a rotary vacuum evaporator at a temperature below the lipid phase 
transition temperature (52±2°C). The rotation speed was set at 25°rpm 
and increased by 25 rpm every 10 min until 150 rpm. Nitrogen was 
then supplied for 3°min primarily to avoid phospholipid oxidation and 
to remove the residual solvent in the flask. The flask was closed tightly 
and kept in the refrigerator (4°C). After 24 h, the thin layer was hydrated 
using a solution containing 500 mg azelaic acid, 8.75 mL ethanol, 100 mg 
propylene glycol, and 15.15 mL phosphate buffer (pH 7.4) at a temperature 
of 40±2°C and 150 rpm. The colloidal suspension obtained (F1) was 
subjected to sonication for 5 min (3 cycles) using the ultrasonic bath 
Bransonic 3200 (47±6 kHz), and then stored in the refrigerator at 4°C.
Cold method
About 500 mg Phospholipon 90G was dissolved in 3 mL ethanol 
(solution 1). Azelaic acid was dissolved in 5.75 mL ethanol (solution 2). 
Solution 2 was added to solution 1 and stirred with a magnetic stirrer. 
Propylene glycol was added and the solution was stirred again (organic 
phase). The preparation was done at room temperature (25±2°C). The 
aqueous phase (phosphate buffer pH 7.4) was added dropwise to the 
organic phase under constant mixing at 700 rpm; the stirring was 
continued for another 30 min [11]. The ethosomal suspensions were 
sonicated in 3 cycles for 5 (F2), 10 (F3), or 15 (F4) min, and stored in 
the refrigerator at 4°C.
Characterization of ethosomes
Morphology
TEM was used to observe the morphology of ethosomes. A drop of the 
sample was placed on a carbon-coated copper grid. Filtration paper 
was used to remove the excess.
Particle-size distribution and zeta potential
Ethosome size distribution and zeta potential were determined using 
dynamic light scattering (DLS) using a Malvern Zetasizer at a scattering 
angle of 173°C. The software Zetasizer was used to process the data.
Entrapment efficiency
Azelaic acid stock solution (1000 ppm) was prepared by dissolving 
azelaic acid in pH 6.8 phosphate buffer and then diluted to concentrations 
of 150, 200, 250, 300, 450, and 600 ppm. The analysis was conducted at 
the maximum absorption wavelength of azelaic acid in pH 6.8 phosphate 
buffer at 204 nm [12]. The absorbance values obtained were plotted 
against concentrations to create a calibration curve. The regression 
equation was y=0.0012x+0.0407 with a correlation efficient (r) of 0.999.
Each of the formulations was placed in a centrifuge tube (Vivaspin 
centrifugal concentrator) with a membrane (5000 kDa) and centrifuged 
at 4000 rpm for 6 h in a LABSCO centrifuge. The supernatant (filtrate) 
was collected and diluted using pH 6.8 phosphate buffer to determine the 
free drug concentration. Total azelaic concentration was determined by 
analyzing diluted samples. The ethosomal suspension and methanol (1:1) 
were added to a 1.5 mL vial, vortexed for 3 min and further diluted. Methanol 
was used to disintegrate the vesicles to obtain more accurate readings. 
A Shimadzu UV-Vis spectrophotometer at 204 nm was used to analyze the 
azelaic acid concentration. The entrapment efficiency was calculated by 
dividing (T–S) with T then times 100% in which EE=Entrapment efficiency 
(%), T=Total azelaic acid concentration in the original suspension, and 
S=Azelaic acid concentration in the supernatant [13].
RESULTS AND DISCUSSION
Thermal analysis
DSC was used to do the thermal analysis. The DSC thermogram 




TEM analysis was conducted to observe ethosome morphology. Due 
to a technical issue, the samples could not be analyzed using the 
same instrument. F1 ethosomes were analyzed using a JEOL JEM1400 
with 2% uranyl acetate, and F4 ethosomes were analyzed using the 
microscope Tecnai 200 kV D2360 SuperTwin. Ethosomes produced 
using the thin-layer hydration method had SUVs and had a spherical 
shape. In theory, the brighter inner part contains ethanol, phosphate 
buffer, and azelaic acid. As seen in Fig. 2, the darker outer part consists 
of a phospholipid bilayer and azelaic acid. As Fig. 3 shows, F4 ethosomes 
had multilamellar and SUV.







Phosphate buffer pH 7.4 100 Fig. 1: Differential scanning calorimetry thermogram
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Particle-size distribution and zeta potential
Table 2 shows the particle-size distributions. As much as 10% of the 
total particles in F1 ethosomes had sizes smaller than 74.57±38.50 nm, 
50% had sizes smaller than 285±62.64 nm, and 90% had sizes smaller 
than 765.67±127.21 nm. Similar data were obtained for F2, F3, and F4 
ethosomes. From the data acquired, the Dmean volume value was used to 
describe the particle size. Table 2 shows that F2, F3, and F4 ethosomes had 
Dmean volumes of 2734.04±231.49, 948.90±394.52, and 931.69±471.84 nm, 
respectively. The PDI values of F2, F3, and F4 ethosomes were higher 
than 0.5 (Table 3), whereas the PDI of F1 ethosomes was 0.39±0.01. F1 
ethosomes had a higher zeta potential (−38.27±1.27 mV) than all those 
prepared using the cold method. Out of the three cold method formulations, 
F2 ethosomes had the lowest value at −23.53±1.04 mV, while F4 ethosomes 
had the highest value (−34.3±1.60 mV).
Entrapment efficiency
The entrapment efficiency indicates the amount of drug trapped 
inside the vesicles. The results in Table 4 show that F1 ethosomes 
had the highest entrapment efficiency with a value of 90.71±0.11%. 
The entrapment efficiency of F2 ethosomes was 53.8±3.16% that 
of F2 ethosomes was 72.56±0.89% and that of F4 ethosomes was 
75.50±1.25%, making F4 ethosomes the most efficient in entrapment 
among all the cold method formulations.
Discussion
Thermal analysis
The transition temperature is the point where phospholipids 
transform from a gel phase to a liquid crystalline phase. Membrane 
fluidity increases during the liquid crystalline phase and the quality 
of vesicles produced decreases because they are susceptible to 
leakage [14]. Phosphatidylcholine is likely to assemble good vesicles 
under its transition temperature. Therefore, 52±2°C was chosen as the 
temperature used in the thin-layer formation method.
Ethosome characterization
Morphology
The vesicles produced using the thin-layer hydration method can be 
categorized as SUVs because they had been sonicated during the formation 
process. A high ethanol concentration (35% v/v) caused the formation of 
thin phospholipid bilayers [11]. F4 ethosomes were chosen to be evaluated 
for the next stage because they had the best characteristics compared to 
F2 and F3 ethosomes. As Fig. 3 shows, F4 ethosomes had multilamellar 
and unilamellar vesicles. Kasetvatin, Rujivipat and Tiyaboonchai showed 
that vesicles do not always have a perfect spherical shape; therefore, the 
vesicles formed (Fig. 3) could still be referred to as ethosomes although 
they were elliptical in shape. The elliptical form can be caused by the high 
concentration of ethanol which increases membrane fluidity. Cholesterol 
can be added to decrease the fluidity [15-18] and produce more spherical 
vesicles. Spherical SUVs were found inside multilamellar vesicles due to 
sonication, which may have disturbed the multilamellar structure and 
created unilamellar vesicles [19]. The inner part of the vesicle in Fig. 3 is 
not as visible as that in Fig. 2 because the sample in Fig. 3 was not stained.
Particle-size distribution and zeta potential
Particle size and zeta potential affect the stability of the ethosomal 
suspension. DLS is a technique used to measure particle size based 
on the velocity of Brownian motion. Brownian motion occurs due to 
the collision of particles with surrounding solvents. The smaller the 
particle size, the greater the Brownian motion [20].
Volume diameter was used in the present study because it shows the 
actual particle size and is more representative and specific (Table 2). 
Table 2 shows that there was a decrease in Dmean volume of F2, F3, 
and F4 ethosomes. Therefore, it can be concluded that the addition of 
sonication to the cold method decreased the particle size of ethosomes.
The PDI value should be <0.5. The degree of heterogeneity of particle-
size distribution is lower when the PDI value is closer to zero [17]. The 
PDI values of F2, F3, and F4 ethosomes were higher than 0.5 (Table 3) 
which indicated rather polydisperse (heterogeneous) suspensions and 
poor particle-size distribution; particle-size distribution curves with 
abnormal distributions and more than one peak. In addition, the TEM 
images (Fig. 3) support the finding that F4 ethosomes vary in particle size. 
The heterogeneity might be due to the sonication time not being optimal, 
resulting in particles with decreased and also increased sizes. The PDI of 
F1 ethosomes was 0.39±0.01 indicating a rather homogeneous suspension 
and a better particle-size distribution than other formulations.
During sonication, sound waves are transmitted through the medium 
and create high and low pressure alternately at a rate depending on the 
frequency. Cavitation occurs during low pressure with high-intensity 
ultrasonic waves forming microscopic vacuum bubbles in the medium. 
These bubbles burst and release high amounts of energy when no more 
energy can be absorbed [19]. This energy causes the breakdown of 
multilamellar layers resulting in a smaller size of unilamellar vesicles.
The particle size of vesicles depends on the intensity of the ultrasonic 
waves and the sonication time. The higher the intensity, the greater the 
cavitation energy released. The longer the sonication time, the longer the 
particles will be exposed to the energy, resulting in a smaller particle size. 
However, if the sonication is too long (beyond the optimum time), it will 
cause agglomeration and increased particle size. Ethosomes prepared 
using thin-layer hydration had bigger particle sizes than those prepared 
using the cold method. F1 ethosomes had an average particle-size diameter 
of 648.57±231.26 nm. F1 ethosomes was prepared by making a thin-layer 
of phospholipid followed by hydration. The thin layer was made at a 
temperature below the transition temperature and then cooled for 24 h at 
Table 2: Particle-size distribution of anti-acne ethosomes
Formulation Average particle-size distribution±SD (nm)
Dv10 Dv50 Dv90 Dmean volume
F1 74.57±38.50 285±62.64 765.67±127.21 648.57±231.26
F2 333.33±40.27 1600.67±577.13 5990±20 2734.04±231.49 
F3 120.67±8.08 501.67±50.29 2334.33±2672.40 948.90±394.52
F4 146.33 ± 40.67 486 ± 55.03 3604.667 ± 2567.55 931.69 ± 471.84
SD: Standard deviation, Dv: Diameter volume
Fig. 3. (a-c) Vesicles of ethosomes
cba
Fig. 2: (a-c) Inner and outer part of ethosomes
cba
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4°C. After hydration at 40±2°C and sonication, the suspension was stored 
at 4°C. These heating and cooling processes made the vesicles formed more 
rigid and less likely to agglomerate. In the cold method, the phospholipids 
were prepared at room temperature (25±2°C). The phospholipids will 
immediately return into a spherical shape in an organic medium and, 
therefore, the vesicles were already formed during the preparation. These 
vesicles are prone to agglomeration, resulting in a greater particle size.
The zeta potential value represents suspension stability. It represents the 
repulsive and attractive forces between the particles. Suspensions are 
known to have better stability when the zeta potential is more negative than 
−30 mV or more positive than +30 mV. F1 ethosomes had the highest stability 
because they had the highest zeta potential (−38.27±1.27 mV) compared to 
ethosomes prepared using the cold method. Among the three cold method 
formulations, F2 ethosomes had the lowest value at −23.53±1.04 mV, while 
F4 ethosomes had the highest value (−34.3±1.60 mV). The presence of 
ethanol resulted in a negative surface charge on the vesicles and a negative 
zeta potential, indicating electrostatic repulsion between particles and 
preventing vesicle aggregation [21].
Entrapment efficiency
The entrapment efficiency of F1 ethosomes was 90.71±0.11%, whereas 
that of F4 ethosomes was 75.50±1.25%, showing that thin-layer 
hydration resulted in the highest entrapment efficiency compared to 
all the cold methods used. The hydration process was done at 40±2°C 
increasing the solubility of azelaic acid, resulting in greater drug trapping. 
However, a sonication time up to 15 min increased the cold method 
entrapment efficiency from 53.84±3.16% to 75.50±1.25%. Sonication 
can increase azelaic acid solubility and breaks down multilamellar 
vesicles, creating unilamellar vesicles. During this process, cavities or 
pores may be formed causing azelaic acid to move into and out of the 
vesicles, increasing entrapment efficiency. Even though azelaic acid 
may be trapped in both the vesicle sac and the phospholipid bilayer, the 
vesicle sac is bigger in volume, resulting in more azelaic acid entrapment 
in SUVs than in small multilamellar vesicles. The vesicles in Fig. 2 were 
unilamellar while those in Fig. 3 were multilamellar.
CONCLUSION
Sonication during vesicle preparation for 15 min in the cold method 
produced spherical, elliptical, multilamellar, and unilamellar anti-
acne ethosomes with a Dmean volume of 931.69±471.84 nm, a PDI of 
0.91±0.03, a zeta potential of −34.3±0.13 mV, and entrapment efficiency 
of 75.11±0.66%. The thin-layer hydration method resulted in better 
characteristics, producing spherical unilamellar ethosomes with a Dmean 
volume of 648.57±231.26 nm, a PDI of 0.38±0.01, a zeta potential of 
38.27±1.72 mV, and an entrapment efficiency of 90.71±0.11%.
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F4 0.91 ± 0.03 −34.3 ± 1.61
SD: Standard deviation, PDI: Polydispersity index
Table 4: Entrapment efficiency of anti-acne ethosomes




F4 75.14 ± 0.66
SD: Standard deviation
